Shelby Wai Ling Lau, | |
1430 Eastlake Pkwy, Chula Vista, CA 91915-1926 | |
(619) 591-7042 | |
Not Available |
Full Name | Shelby Wai Ling Lau |
---|---|
Gender | Female |
Speciality | Pharmacist |
Location | 1430 Eastlake Pkwy, Chula Vista, California |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1023706876 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
183500000X | Pharmacist | 87861 (California) | Primary |
Mailing Address | Practice Location Address |
---|---|
Shelby Wai Ling Lau, 11526 Windcrest Ln Apt 366, San Diego, CA 92128-4268 Ph: (415) 269-9289 | Shelby Wai Ling Lau, 1430 Eastlake Pkwy, Chula Vista, CA 91915-1926 Ph: (619) 591-7042 |
News Archive
A collaboration, led by scientists at the Garvan Institute of Medical Research and the University of New South Wales (UNSW) in Sydney, has discovered the first risk gene specifically for bipolar disorder, also known as manic-depressive illness. This means that people who have a particular form of this gene are twice as likely to develop the disease.
A method of producing synthetic bone, using techniques normally used to make catalytic converters for cars, is being developed by researchers at WMG at the University of Warwick.
The United States Agency for International Development (USAID) has awarded a five-year grant, Strengthening Health Outcomes through the Private Sector, to Abt Associates, Inc. Sub-recipients under the grant are Banyan Global, Jhpiego, Marie Stopes International, the Monitor Group, and O'Hanlon Health Consulting, LLC.
Bristol-Myers Squibb Company today announced results from a Phase II clinical trial in which treatment with the investigational direct-acting antiviral BMS-790052, an NS5A replication complex inhibitor, in combination with PEG-Interferon alfa and ribavirin, achieved sustained virologic response 12 weeks post-treatment in up to 92% of treatment-naïve patients chronically infected with hepatitis C genotype 1.
› Verified 2 days ago
Dr. Michael Elyea, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1400 E Palomar St, Chula Vista, CA 91913 Phone: 619-397-3072 | |
Dr. Evelyn Hawson, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 895 E H St, Chula Vista, CA 91910 Phone: 619-482-4405 | |
Ana Creps, PHARM D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1376 3rd Ave, Chula Vista, CA 91911 Phone: 619-691-0662 Fax: 619-691-6811 | |
Richard Bonnoront, PHARM-D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1400 E Palomar St, Chula Vista, CA 91913 Phone: 619-397-3060 | |
Mark Erdrich, PHARMACIST Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 740 Otay Lakes Rd, Chula Vista, CA 91910 Phone: 858-373-7856 | |
Mary Mcdermott, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 525 3rd Ave, Suite A, Chula Vista, CA 91910 Phone: 619-420-7120 |